These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 6155247)
1. [Effect of SQ-20881, an inhibitor of carboxycathepsin (angiotensin I-converting enzyme), on peripheral circulation during the early postresuscitation period]. Orekhovich VN; Eliseeva IuE; Pavlikhina LV; Negovskiĭ VA; Novoderzhkina IS Dokl Akad Nauk SSSR; 1980; 250(1):253-6. PubMed ID: 6155247 [No Abstract] [Full Text] [Related]
2. [Peptides--inhibitors of carboxycathepsin (peptidyl-dipeptidase A) and their role in clinical medicine]. Orekhovich VN; Eliseeva IuE; Pavlikhina LV; Krit NA; Filatova MP Vopr Med Khim; 1984; 30(3):51-6. PubMed ID: 6206649 [TBL] [Abstract][Full Text] [Related]
3. Effect of the converting enzyme inhibitor SQ-20881 on urinary excretion of prostaglandin E2 in the rat: influence of pretreatment with deoxycorticosterone. Barr JG; Diz D; Kauker ML; Nasjletti A J Pharmacol Exp Ther; 1980 Oct; 215(1):172-5. PubMed ID: 6161243 [TBL] [Abstract][Full Text] [Related]
4. Effect of the inhibition of angiotensin converting enzyme on renin release mediated by exercise in man [proceedings]. Khokhar AM; Havard CW; Slater JD J Endocrinol; 1979 Oct; 83(1):37P-38P. PubMed ID: 230274 [No Abstract] [Full Text] [Related]
5. Effects of angiotensin converting enzyme inhibitor on cardiovascular response to lower body negative pressure [proceedings]. Adigun SA; Clough D; Conway J; Hatton R J Physiol; 1980 Jan; 298():30P-31P. PubMed ID: 6153719 [No Abstract] [Full Text] [Related]
6. The inhibition of rat renin in sodium depleted and renal hypertensive rats. Comparison of purified antibodies or Fab fragments against mouse submaxillary renin with SQ 20881, and the effect on blood pressure homeostasis. Lykkegård S Scand J Urol Nephrol Suppl; 1984; 79():17-22. PubMed ID: 6206557 [TBL] [Abstract][Full Text] [Related]
7. [Human erythrocyte prolyl endopeptidase II hydrolysing teprotid, an inhibitor of peptidyl peptidase from snake venom]. Alekseenko LP; Orekhovich VN Biull Eksp Biol Med; 1985 Mar; 99(3):308-11. PubMed ID: 2985149 [TBL] [Abstract][Full Text] [Related]
8. [Central hemodynamics of dogs in the early postresuscitation period and the outcome of resuscitation]. Boliakina GK Biull Eksp Biol Med; 1979 Nov; 88(11):530-2. PubMed ID: 540136 [TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of the converting enzyme inhibitor teprotide in normal- and high-renin hypertension. Niarchos AP; Pickering TG; Wallace JM; Case DB; Laragh JH Clin Pharmacol Ther; 1980 Nov; 28(5):592-601. PubMed ID: 6160013 [TBL] [Abstract][Full Text] [Related]
10. Role of the renin-angiotensin system in blood pressure regulation. The cardiovascular effects of converting enzyme inhibition in normotensive subjects. Niarchos AP; Pickering TG; Case DB; Sullivan P; Laragh JH Circ Res; 1979 Dec; 45(6):829-37. PubMed ID: 498446 [No Abstract] [Full Text] [Related]
11. Comparison of intrarenal and extrarenal converting-enzyme inhibition by SQ 20 881 on canine renal blood flow. Wong PC; Zimmerman BG Clin Sci (Lond); 1981 Nov; 61(5):553-7. PubMed ID: 6169480 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-dependent hypertension--potential pitfalls in definition. Williams GH N Engl J Med; 1977 Mar; 296(12):684-5. PubMed ID: 190538 [No Abstract] [Full Text] [Related]
13. Captopril and teprotide as discriminators of angiotensin-converting enzyme activity in brain tissue. Zubenko GS; Nixon RA Neurosci Lett; 1985 Sep; 60(1):33-7. PubMed ID: 2997673 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular responses to isometric exercise and standing in normotensive subjects during converting enzyme inhibition with teprotide. Niarchos AP; Pickering TG; Laragh JH Hypertension; 1982; 4(4):538-44. PubMed ID: 6185419 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep. Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038 [TBL] [Abstract][Full Text] [Related]
16. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats. Takata Y; Di Nicolantonio R; Hutchinson JS Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035 [TBL] [Abstract][Full Text] [Related]
17. Effects of the nonapeptide SQ 20.881 on the blood pressure of conscious normotensive and chronic hypertensive mice. Svendsen UG Acta Pathol Microbiol Scand A; 1977 Nov; 85(6):942-4. PubMed ID: 602780 [TBL] [Abstract][Full Text] [Related]
18. RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis. Junot C; Gonzales MF; Ezan E; Cotton J; Vazeux G; Michaud A; Azizi M; Vassiliou S; Yiotakis A; Corvol P; Dive V J Pharmacol Exp Ther; 2001 May; 297(2):606-11. PubMed ID: 11303049 [TBL] [Abstract][Full Text] [Related]
19. Failure of chronic administration of the angiotensin I-converting enzyme inhibitor, Teprotide (SQ 20881), to affect the ultrastructure of the adrenal cortex and the aldosterone secretion in the rat. Weaver J; Nickerson PA; Molteni A; Solliday N; Albertson D Lab Invest; 1981 Dec; 45(6):527-33. PubMed ID: 6172661 [TBL] [Abstract][Full Text] [Related]
20. Increase in cyclic AMP levels and vasopressin release in response to angiotensin I in neurohypophyses: blockade following inhibition of the converting enzyme. Sirois P; Gagnon DJ J Neurochem; 1975 Nov; 25(5):727-9. PubMed ID: 172607 [No Abstract] [Full Text] [Related] [Next] [New Search]